This is information on the duration of CTN-0094 trial periods.
Usage
data(meta_study_length)
Format
A tibble with 16 rows and 6 variables:
- project
Type: factor (First/Reference level = 27) Description: CTN project number Levels: 27, 30, 51 - treatment
Type: factor (First/Reference level = Inpatient BUP) Description: - ctn_0027:
- Methadone
- Outpatient BUP
- ctn_0030:
- Outpatient BUP + EMM
- Outpatient BUP + SMM
- ctn_0051:
- Outpatient BUP + EMM
- Outpatient BUP + SMM
Levels: Inpatient BUP, Inpatient NR-NTX, Methadone, Outpatient BUP, Outpatient BUP + EMM, Outpatient BUP + SMM - ctn_0027:
- phase
Type: factor (First/Reference level = 1) Description: Study phase (needed because of CTN 30) Levels: 1, 2 - stage
Type: factor (First/Reference level = 1) Description: Treatment stage used with description
to capture different treatment phase/stage/periodLevels: 1, 2, 3 - weeks
Type: integer Description: Treatment duration in weeks - description
Type: factor (First/Reference level = Buprenorphine-naloxone stabilization) Description: Description of the treatment duration Levels: Buprenorphine-naloxone stabilization, Buprenorphine-naloxone treatment, Post-medication follow-up, Taper, Treatment